PART1 and hepatocellular carcinoma: The above results suggest that PART1 acts as an endogenous sponge for miR-490-3p in HCC cells to promote the expression of SLC7A11 and may promote HCC progression and inhibit ferroptosis through the miR-490-3p/SLC7A11 axis.